BDBM92388 Oxaliplatin, 3
- Tanini, D; Carradori, S; Capperucci, A; Lupori, L; Zara, S; Ferraroni, M; Ghelardini, C; Mannelli, L; Micheli, L; Lucarini, E; Carta, F; Angeli, A; Supuran, CT Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action. Eur J Med Chem 225: (2021)
- Angeli, A; Micheli, L; Carta, F; Ferraroni, M; Pirali, T; Fernandez Carvajal, A; Ferrer Montiel, A; Di Cesare Mannelli, L; Ghelardini, C; Supuran, CT First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. J Med Chem 66: 1616-1633 (2023)
- Fragai, M; Comito, G; Di Cesare Mannelli, L; Gualdani, R; Calderone, V; Louka, A; Richichi, B; Francesconi, O; Angeli, A; Nocentini, A; Gratteri, P; Chiarugi, P; Ghelardini, C; Tadini-Buoninsegni, F; Supuran, CT; Nativi, C Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-Induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX). J Med Chem 60: 9003-9011 (2017)
- Narayan, S; Ramisetti, S; Jaiswal, AS; Law, BK; Singh-Pillay, A; Singh, P; Amin, S; Sharma, AK ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. Eur J Med Chem 161: 456-467 (2019)
- Nocentini, A; Alterio, V; Bua, S; Micheli, L; Esposito, D; Buonanno, M; Bartolucci, G; Osman, SM; ALOthman, ZA; Cirilli, R; Pierini, M; Monti, SM; Di Cesare Mannelli, L; Gratteri, P; Ghelardini, C; De Simone, G; Supuran, CT Phenyl(thio)phosphon(amid)ate Benzenesulfonamides as Potent and Selective Inhibitors of Human Carbonic Anhydrases II and VII Counteract Allodynia in a Mouse Model of Oxaliplatin-Induced Neuropathy. J Med Chem 63: 5185-5200 (2020)